Article: Identification of vitamin D receptor as a target of p63.
2006 Volume 25, Issue 26, Page(s) 3745–3751
Abstract: p63, a p53 homolog has been shown to play a role in development and cancer. p63 is essential for both commitment of ectoderm to stratified epithelia and for the proliferative potential of epithelial stem cells. p63 knockout mice are born with severe ... ...
Abstract | p63, a p53 homolog has been shown to play a role in development and cancer. p63 is essential for both commitment of ectoderm to stratified epithelia and for the proliferative potential of epithelial stem cells. p63 knockout mice are born with severe development defects and lack organs of epithelial origin. In addition, p63 has also been shown to play a role in cancer development through the differential regulation of genes with tumor suppressor function and genes involved in metastasis. In order to understand the role of p63 in cancer and development, genes that are specifically regulated by p63 but not p53 were identified. In this study, we provide evidence that p63gamma specifically upregulates vitamin D Receptor (VDR). In contrast, p53 does not appear to be involved in upregulation of VDR expression. Additionally, we demonstrate that a naturally occurring p63 missense mutant, p63gamma (R279H) and p14(ARF), both act in a dominant negative manner to inhibit p63gamma-mediated upregulation of VDR. Furthermore, using chromatin immunoprecipitation assays, we demonstrated that p63 directly binds to the VDR promoter in vivo. Our findings clearly demonstrate that VDR is a direct target of p63 and suggests that p63 may play a role in cancer and differentiation through modulation of the VDR pathway. |
---|---|
MeSH term(s) | Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Cell Differentiation/genetics ; Chromatin Immunoprecipitation ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Gene Expression Regulation ; HeLa Cells ; Humans ; Mutation, Missense ; Osteosarcoma/genetics ; Osteosarcoma/pathology ; Promoter Regions, Genetic ; Receptors, Calcitriol/genetics ; Receptors, Calcitriol/metabolism ; Response Elements ; Trans-Activators/genetics ; Trans-Activators/metabolism ; Transcription Factors ; Tumor Cells, Cultured ; Tumor Suppressor Protein p14ARF/genetics ; Tumor Suppressor Protein p14ARF/metabolism ; Tumor Suppressor Proteins/genetics ; Tumor Suppressor Proteins/metabolism |
Chemical Substances | DNA-Binding Proteins ; Receptors, Calcitriol ; TP63 protein, human ; Trans-Activators ; Transcription Factors ; Tumor Suppressor Protein p14ARF ; Tumor Suppressor Proteins |
Language | English |
Publishing date | 2006-06-22 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 639046-8 |
ISSN | 1476-5594 ; 0950-9232 |
ISSN (online) | 1476-5594 |
ISSN | 0950-9232 |
DOI | 10.1038/sj.onc.1209412 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2218: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.